Left Ventricular Systolic Dysfunction: Clinical Trials

1 trial for Left Ventricular Systolic Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Left Ventricular Systolic Dysfunction: new trials by email Literature Review of Left Ventricular Systolic Dysfunction trials Research Report on Left Ventricular Systolic Dysfunction

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure
Omecamtiv Mecarbil Matrix F1 Formulation, Omecamtiv Mecarbil Matrix F2 Formulation, Placebo - Modified Release Oral Formulation, Left Ventricular Systolic Dysfunction
Phase 2CompletedCytokinetics5442013-02-262021-08-12

Narrower conditions

Ventricular Dysfunction, Left (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Ventricular Dysfunction (1)

Interventions

omecamtiv mecarbil (1)

Sponsors

Cytokinetics (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Lithuania (1)  ·  Netherlands (1)  ·  Poland (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 33176437, PMID 33176443, PMID 33826209